Myra Noorely WIDJOJOATMODJO,Olivier GODEAUX,Kristi Lynn WILLIAMS,Benoit Christophe Stephan CALLENDRET,Jerald C. SADOFF
申请号：
US16642082
公开号：
US20200197509A1
申请日:
2018.09.13
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Methods of inducing a safe immune response against respiratory syncytial virus (RSV) in a human subject in need thereof, including administering to the subject a composition including recombinant adenovirus including a nucleic acid encoding an RSV Fusion (F) protein including the amino acid sequence of SEQ ID NO: 1, and a pharmaceutically acceptable carrier, in a total dose of from about 1×1010 to about 2×1011 viral particles (vp), are described.
